On March 18, China SXT Pharmaceuticals Inc. (SXTC) was trending in the premarket with a gain of 12.53% at the last check. With no official
Alterity Therapeutics Limited (ATHE) stock plunged -10.31% to $2.0 in the pre-market trading after the company announced the approval of a US patent for the
The global generics drug market continues to grow with the increasing demand for more medication. Drug manufacturers are continuously striving to meet the need for
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.